|
23.2.2015 |
EN |
Official Journal of the European Union |
C 65/49 |
Action brought on 22 December 2014 — Alnapharm v OHIM — Novartis (Alrexil)
(Case T-839/14)
(2015/C 065/66)
Language in which the application was lodged: English
Parties
Applicant: Alnapharm GmbH & Co. KG (Hamburg, Germany) (represented by: H. Heldt, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)
Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)
Details of the proceedings before OHIM
Applicant: The other party to the proceedings before the Board of Appeal
Trade mark at issue: Community word mark ‘Alrexil’ — Application for registration No 10 306 249
Procedure before OHIM: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of OHIM of 23 October 2014 in Case R 1723/2013-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision and refer the case back to the Board of Appeal of OHIM; |
|
— |
order OHIM to pay the costs. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009. |